Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions with FDA on the Development of Denifanstat for MASH; Phase 3 Program Initiation Expected by End of 2024

1 year ago

The planned registration program consists of two double-blind, placebo-controlled multicenter Phase 3 trials, FASCINATE-3 and FASCINIT, to evaluate the safety…

Quris-AI Acquires Nortis

1 year ago

Adds Proven Kidney-on-Chip Technology to Its Pioneering Bio-AI PlatformBOSTON and TEL AVIV, Israel, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Quris-AI…

Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024

1 year ago

WATERTOWN, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics…

Breckenridge Distillery and Flaviar Partner to Release Dad’s Stash Whiskey in Support of No-Shave November, Raising Funds for Fight Colorectal Cancer (Fight CRC)

1 year ago

BRECKENRIDGE, Colo., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Breckenridge Distillery, one of the most-awarded craft distilleries in the U.S. and a…

First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)

1 year ago

Randomized, controlled study will be first in personalized spacing evidence to include patients who have a prostate cancer recurrence after…

Medigene to Present at Upcoming Investor Conferences

1 year ago

Planegg/Martinsried, October 29, 2024. Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on…

FendX Announces Grant of Japanese Patent to Protect REPELWRAP(TM) Film

1 year ago

Japanese Patent Represents FendX's 4th Patent IssuedOakville, Ontario--(Newsfile Corp. - October 29, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB:…

Pioneering Insights: ERG, Lotus, and GMG Unveil Study on the potential impact of GLP-1 Agonists and Cognitive Health in Diabetes and Obesity

1 year ago

NEW PROVIDENCE, N.J., Oct. 29, 2024 /PRNewswire/ -- Evolution Research Group (ERG) and Lotus, portfolio companies of Emerge HoldCo, LLC, in…

Linus Health to Demonstrate How Digital Health Powers Innovation at Clinical Trials on Alzheimer’s Disease (CTAD)

1 year ago

Leaders to deliver four poster presentations showing how its digital health platform lowers investigator burden, enables precision recruitment, and delivers…